Company / Free Cash Flow
STAAR Surgical Company Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$40.0M
FY2025
5-year range
-$40.0M / $17.6M
FY2021-FY2025
Trend
-422.2%
vs FY2024
Sector context
#130 of 151
Health Care
What the data says
Free Cash Flow changed -422% YoY in FY2025, a notable deviation from the 9-year average annual change of +17%.
Based on SEC 10-K filings.
-$40M in FY2025.
Declined from -$4M to -$40M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 151This company -$40.0M Sector average $779.8M
▼
-105.1% below sector average
Key checks
Key Insights
- STAAR Surgical Company's free cash flow has declined for 3 consecutive years.
- In FY2025, free cash flow decreased 422.2% year-over-year.
- Ranks #130 out of 151 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$40.0M | -422.2% |
| FY2024 | -$7.7M | -113.4% |
| FY2023 | -$3.6M | -120.4% |
| FY2022 | $17.6M | +12.1% |
| FY2021 | $15.7M | +49.2% |
| FY2020 | $10.5M | -33.0% |
| FY2019 | $15.7M | +828.2% |
| FY2018 | -$2.2M | +48.8% |
| FY2017 | -$4.2M | -95.1% |
| FY2016 | -$2.2M | +48.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026